The authors suggest that a routine follow-up of creatine-phosphokinase and cardiac troponin I, as well as Electrocardiogram monitoring, should be performed to identify early any possible ICI-induced myocarditis and myositis. This evidence concerns the gene TNNI3 and myositis disease.